H. Schimmelpenning
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 5
- Colorectal Cancer Surgical Treatments 5
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 4
- Pancreatic and Hepatic Oncology Research 3
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 12
- Immunology and Allergy top 10%
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Gert AuerR. BrollM. DuchrowElina ErikssonMartin StrikHans‐Peter BruchAnders ZetterbergJens K. Habermann
- Partner nations
- GermanySwedenUnited States
In The Last Decade
H. Schimmelpenning
29 papers receiving 633 citations
Peers
Comparison fields: 5 of 63
- Oncology 380
- Pathology and Forensic Medicine 206
- Cancer Research 151
- Immunology and Allergy 43
- Surgery 240
Countries citing papers authored by H. Schimmelpenning
This map shows the geographic impact of H. Schimmelpenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Schimmelpenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Schimmelpenning more than expected).
Fields of papers citing papers by H. Schimmelpenning
This network shows the impact of papers produced by H. Schimmelpenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Schimmelpenning. The network helps show where H. Schimmelpenning may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Schimmelpenning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2020 | 20 | |
| 3 | 2010 | 29 | |
| 4 | 2003 | 17 | |
| 5 | 2001 | 26 | |
| 6 | 2001 | 23 | |
| 7 | 2001 | 32 | |
| 8 | 2000 | 1 | |
| 9 | 2000 | 1 | |
| 10 | 1999 | 15 | |
| 11 | 1998 | 13 | |
| 12 | 1997 | 105 | |
| 13 | 1996 | 32 | |
| 14 | 1996 | 16 | |
| 15 | 1993 | 6 | |
| 16 | Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer. | 1992 | 18 |
| 17 | Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ. | 1992 | 36 |
| 18 | 1992 | 11 | |
| 19 | 1992 | 25 | |
| 20 | 1990 | 11 |
About H. Schimmelpenning
H. Schimmelpenning is a scholar working on Pathology and Forensic Medicine, Oncology and Oral Surgery, having authored 31 papers that have together received 654 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer-related Molecular Pathways (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (380 citations), Pathology and Forensic Medicine (206 citations) and Cancer Research (151 citations). H. Schimmelpenning has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Gert Auer, R. Broll, M. Duchrow, Elina Eriksson, Martin Strik, Hans‐Peter Bruch, Anders Zetterberg, Jens K. Habermann, Alexander Woltmann and Uwe J. Roblick. Their work appears in journals such as Cancer, Annals of Surgery and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.